Skip to main content
KALA
NASDAQ Life Sciences

KALA BIO Licenses AI Platform, Reports Q1 Loss Cut to $1.6M, Extends Cash Runway to Q2 2027

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.902
Mkt Cap
$54.468M
52W Low
$2.85
52W High
$1,030
52W Position info
1.8% above low
Off High info
100% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

KALA is trading near its 52-week low of $2.85 (1.8% above the low) on light trading volume (0.3× avg).

Summary

KALA BIO announced an exclusive license and development deal for the Researgency Platform, signaling a strategic shift towards an AI platform. The company also reported a Q1 2026 net loss of $1.6 million, a significant improvement from $8.9 million year-earlier, and secured new financing that extends its cash runway into Q2 2027. This comprehensive update provides specific, positive financial details that were not fully disclosed in the recent 10-Q, which only hinted at a "substantial reduction" in net loss. For a small biotech company trading near its 52-week low, the combination of a new strategic partnership, significantly reduced losses, and an extended cash runway is highly material, potentially alleviating immediate financial concerns and offering a new growth narrative.

At the time of this announcement, KALA was trading at $2.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $54.5M. The 52-week trading range was $2.85 to $1,030.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

KALA - Latest Insights

KALA
Nov 12, 2026, 8:00 AM EST
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.149
Real-time Price: $0.1414 info
Change: Reverse Stock Split info
Market Cap: $2.735M info
KALA
Nov 09, 2026, 8:00 AM EST
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.1568
Real-time Price: $0.1414 info
Change: Reverse Stock Split info
Market Cap: $2.735M info
KALA
Sep 29, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.474
Real-time Price: $0.1414 info
Change: Reverse Stock Split info
Market Cap: $2.735M info
KALA
Sep 24, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.5288
Real-time Price: $0.1414 info
Change: Reverse Stock Split info
Market Cap: $2.735M info
KALA
Sep 11, 2026, 4:56 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.590
Real-time Price: $0.1414 info
Change: Reverse Stock Split info
Market Cap: $2.735M info